Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 17 Nov 2021 07:00 CET |
PCI BIOTECH HOLDING | PCI Biotech Q3 2021 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 09 Nov 2021 12:50 CET |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to Q3 2021 result presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Nov 2021 09:30 CET |
PCI BIOTECH HOLDING | PCI Biotech to present at the 9th International mRNA Health Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Nov 2021 11:15 CET |
PCI BIOTECH HOLDING | PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Sep 2021 18:20 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Employee share option scheme | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 31 Aug 2021 12:38 CEST |
PCI BIOTECH HOLDING | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Aug 2021 07:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech first half-year 2021 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 23 Aug 2021 10:00 CEST |
PCI BIOTECH HOLDING | PCI Biotech: Invitation to first half-year 2021 result presentation | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 Jun 2021 08:32 CEST |
PCI BIOTECH HOLDING | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |